Biomerica (BMRA) Asset Writedowns and Impairment (2016 - 2026)
Biomerica's Asset Writedowns and Impairment history spans 16 years, with the latest figure at -$59000.0 for Q1 2026.
- On a quarterly basis, Asset Writedowns and Impairment fell 5800.0% to -$59000.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $12000.0, a 300.0% increase, with the full-year FY2025 number at $8000.0, up 180.0% from a year prior.
- Asset Writedowns and Impairment hit -$59000.0 in Q1 2026 for Biomerica, down from $32000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for BMRA hit a ceiling of $478000.0 in Q2 2023 and a floor of -$505000.0 in Q1 2023.
- Historically, Asset Writedowns and Impairment has averaged $32242.5 across 5 years, with a median of $1000.0 in 2024.
- Biggest five-year swings in Asset Writedowns and Impairment: crashed 6647.73% in 2023 and later skyrocketed 900.0% in 2025.
- Tracing BMRA's Asset Writedowns and Impairment over 5 years: stood at $139000.0 in 2022, then surged by 243.88% to $478000.0 in 2023, then plummeted by 100.84% to -$4000.0 in 2024, then skyrocketed by 900.0% to $32000.0 in 2025, then plummeted by 284.38% to -$59000.0 in 2026.
- Business Quant data shows Asset Writedowns and Impairment for BMRA at -$59000.0 in Q1 2026, $32000.0 in Q4 2025, and $38000.0 in Q3 2025.